DIN 02473909 — BESPONSA 0.9 MG
BESPONSA is a powder for solution of Inotuzumab Ozogamicin marketed by PFIZER CANADA ULC. The full Inotuzumab Ozogamicin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02473909
- Brand name
- BESPONSA
- Active ingredient
- Inotuzumab Ozogamicin
- Strength
- 0.9 MG
- Dosage form
- POWDER FOR SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- PFIZER CANADA ULC
- Health Canada status
- MARKETED
- Drug class
- CD22-directed antibody-drug conjugate (antineoplastic agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.